Primary Sources

McCrory, P., Meeuwisse, W., Dvorak, J., et al. (2017). Consensus statement on concussion in sport — the 5th International Conference on Concussion in Sport held in Berlin, October 2016. British Journal of Sports Medicine, 51(11), 838–847. Patricios, J.S., Schneider, K.J., Dvorak, J., et al. (2023). Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport — Amsterdam, October 2022. British Journal of Sports Medicine, 57(11), 695–711. Giza, C.C., & Hovda, D.A. (2014). The new neurometabolic cascade of concussion. Neurosurgery, 75(Suppl 4), S24–S33. Langlois, J.A., Rutland-Brown, W., & Wald, M.M. (2006). The epidemiology and impact of traumatic brain injury. Journal of Head Trauma Rehabilitation, 21(5), 375–378. McKee, A.C., et al. (2023). Neuropathologic and clinical findings in young contact sport athletes. JAMA Neurology. Barlow, K.M. (2016). Postconcussion syndrome: a review. Journal of Child Neurology, 31(1), 57–67.

Chapter 1: Foundations — Anatomy, Epidemiology, and Definitions

The Nature of Concussion

Concussion occupies an unusual position in clinical medicine: it is among the most commonly diagnosed neurological conditions in athletes and the general population, yet it remains one of the least uniformly defined. The term itself derives from the Latin concutere, meaning “to shake violently,” and the clinical syndrome it denotes has been recognized in some form since antiquity. Nevertheless, the precise biological boundaries of concussion — where it begins, how it differs from more severe traumatic brain injury, and when it ends — have been subjects of intense scientific and clinical debate throughout the modern era. Understanding concussion rigorously requires first establishing what the condition is, then building outward from that definitional anchor into mechanism, presentation, management, and consequence.

The Berlin (2017) consensus definition, updated in Amsterdam (2023), characterizes sport-related concussion as “a traumatic brain injury induced by biomechanical forces, either a direct blow to the head, face, neck, or elsewhere on the body with an impulsive force transmitted to the head.” This definition is notable for several things it deliberately includes and excludes. It explicitly encompasses indirect mechanisms — a blow to the body that transmits inertial loading to the head can produce concussion just as surely as direct head contact. It specifies that concussion typically results in the rapid onset of short-lived neurological impairment that resolves spontaneously, although symptoms and signs may evolve over minutes to hours and the acute clinical picture need not include loss of consciousness. Importantly, the definition anchors the diagnosis in functional rather than structural disruption: standard structural neuroimaging (CT, standard MRI) is characteristically normal, even when significant symptomatology persists.

The distinction between concussion and moderate-to-severe traumatic brain injury (TBI) is clinically critical. Moderate TBI is generally defined by either a Glasgow Coma Scale (GCS) score of 9–12 at presentation, loss of consciousness exceeding 30 minutes, or post-traumatic amnesia lasting between 30 minutes and 24 hours. Severe TBI is characterized by GCS ≤ 8, LOC exceeding 24 hours, or intracranial structural injury on neuroimaging. Concussion, by contrast, occupies the “mild” tier: GCS of 13–15, LOC if present lasting less than 30 minutes, and post-traumatic amnesia under 24 hours. However, it is crucial not to conflate “mild” with “trivial.” The mTBI category encompasses a wide spectrum of physiological disruption, and the word mild describes injury severity classification within the TBI spectrum, not the impact on a patient’s life. For many individuals, the functional consequences of concussion are anything but mild, and the persistent concussion symptom literature documents prolonged disability lasting months or even years in a meaningful proportion of those affected.

Epidemiologically, concussion is among the most prevalent neurological injuries across the lifespan. Estimates vary widely because of inconsistent case definitions, underreporting, and heterogeneous study designs, but current best estimates suggest approximately 1.6 to 3.8 million sport-related concussions occur annually in the United States alone, with substantial additional burden from motor vehicle collisions, falls, and occupational exposures. In Canadian sport, ice hockey, football, soccer, and rugby carry the highest incidence rates. It is widely acknowledged that true incidence substantially exceeds reported incidence, with numerous studies suggesting that athletes fail to report concussive events because of perceived stigma, concern about losing playing time, lack of symptom recognition, or deliberate concealment from coaches and clinicians. This underreporting problem complicates epidemiological estimates and underscores the importance of education and surveillance programs.

Neuroanatomy Relevant to Concussion

The Skull and Meningeal Layers

The brain is protected by a series of concentric barriers that collectively buffer it against mechanical forces, provide immunological privilege, and maintain the chemical microenvironment necessary for neural function. Understanding these layers is not merely anatomical housekeeping — each layer is implicated in specific aspects of concussion pathophysiology, particularly in terms of how forces are transmitted, how pressure gradients develop, and how the brain can sustain injury despite an apparently intact skull.

The cranial vault is composed of an outer cortical table, a diploe layer of trabecular bone containing red marrow and venous sinuses, and an inner cortical table. The inner cortical surface is irregular, featuring bony prominences and ridges — particularly at the anterior cranial fossa, over the lesser wings of the sphenoid bone, and at the petrous ridges — that can lacerate brain tissue when the organ is set in motion relative to the skull. The skull’s overall geometry matters too: the spheroidal shape of the cranium determines how forces applied at one point are redistributed across the vault, and finite element modeling has shown that stress concentrations develop predictably at specific anatomical sites depending on impact location and direction.

The dura mater is a dense, leathery membrane consisting of two layers: a periosteal layer (adhering to the inner skull) and a meningeal layer (which encloses the brain proper). At several locations the meningeal dura folds inward to form dural reflections: the falx cerebri separates the two cerebral hemispheres longitudinally, the tentorium cerebelli separates the cerebral hemispheres from the cerebellum inferiorly, and the falx cerebelli partially divides the two cerebellar hemispheres. These rigid dural partitions play an important role in concussion biomechanics because they constrain the motion of specific brain compartments while allowing others to move more freely. When rotational acceleration is applied, the brain can torque against these dural boundaries, generating shear forces at the brain-falx interface, at the level of the corpus callosum (which lies just beneath the falx), and at the tentorial notch — the opening through which the brainstem passes. Herniation syndromes in severe TBI exploit this anatomy, but even in concussion, the distribution of biomechanical stress follows these anatomical boundaries.

The arachnoid mater and the subarachnoid space (SAS) are particularly important in concussion because the CSF within the SAS functions as a hydraulic cushion. However, this cushioning is not unlimited: sudden accelerations transmit pressure waves through CSF that can cause coup injury at the site of impact (where positive pressure develops) and contrecoup injury at the contralateral site (where cavitation-related negative pressure develops). The bridging veins that drain cortical blood into the dural venous sinuses traverse the SAS and are susceptible to tearing under sufficient rotational strain, producing subdural hematomas — a distinction from concussion that the clinician must always keep in mind. The pia mater, adhering so closely to the cortical surface that it dips into every sulcus and gyrus, represents the inner boundary of the SAS and the effective outer boundary of the brain parenchyma.

CSF Circulation

Cerebrospinal fluid is produced primarily by the choroid plexus — highly vascularized epithelial structures located within the lateral, third, and fourth ventricles — at a rate of approximately 500 mL per day, although the total CSF volume at any moment is only about 140–150 mL. This implies that CSF turns over roughly three to four times per day. The circulation follows a predictable path: from the lateral ventricles through the interventricular foramina of Monro into the third ventricle, then through the cerebral aqueduct of Sylvius into the fourth ventricle, and finally out through the lateral foramina of Luschka and the midline foramen of Magendie into the subarachnoid space surrounding the brain and spinal cord. Reabsorption occurs primarily at the arachnoid granulations (Pacchionian bodies) that project into the dural venous sinuses, driven by the pressure gradient between CSF and venous blood.

CSF serves multiple functions beyond mechanical protection. It provides a controlled chemical milieu for neural tissue — its ionic composition differs measurably from plasma, with lower potassium, calcium, and protein concentrations — and it provides a “waste clearance” function via the recently characterized glymphatic system, a perivascular pathway through which interstitial fluid and metabolic waste products (including amyloid-beta and tau proteins) are cleared from the brain parenchyma during sleep. This glymphatic clearance function has profound implications for understanding post-concussion sleep disturbance as not merely a symptom but potentially a pathophysiological factor that prolongs metabolic dysfunction by impairing waste clearance from the injured brain.

Brain Regions and Their Vulnerability

The anatomical vulnerability of specific brain regions to concussive injury is not uniform. Rather, it is governed by the mechanical properties of tissue at each location, the geometry of the brain’s relationship to surrounding structures, and the metabolic demands and connectivity patterns of each region.

The prefrontal cortex’s vulnerability extends beyond its anatomical position. The PFC maintains dense bidirectional connections with the limbic system (particularly the amygdala and hippocampus via the uncinate fasciculus and cingulate cortex), with the basal ganglia, and with sensory association cortices via long-range white matter tracts. These distributed network connections make the PFC a hub node — its disruption affects not just executive function per se but the regulation of emotion, the consolidation of declarative memories, and the modulation of attention. Post-concussion cognitive complaints — feeling “foggy,” difficulty concentrating, slowed thinking — largely reflect PFC network disruption rather than isolated focal damage.

The limbic system, broadly conceived as including the hippocampus, amygdala, cingulate cortex, parahippocampal gyrus, and hypothalamus, is deeply involved in memory formation, emotional processing, stress response, and autonomic regulation. The hippocampus is exquisitely sensitive to excitotoxic injury because of the high density of NMDA (N-methyl-D-aspartate) receptors on hippocampal CA1 and CA3 pyramidal neurons — receptors that are central to the neurometabolic cascade following concussion (discussed in Chapter 3). Post-traumatic amnesia — the inability to form new memories for events following injury — reflects this hippocampal vulnerability. The amygdala’s role in processing threat and emotional salience explains why concussed individuals frequently report heightened emotional reactivity, anxiety, and irritability that seems disproportionate to the cognitive severity of their injury.

The brainstem and cerebellum deserve special attention in concussion neuroanatomy for several reasons. The brainstem — comprising the midbrain, pons, and medulla — houses ascending arousal systems (the reticular activating system), cranial nerve nuclei governing eye movements (CN III, IV, VI), the vestibular nuclei (CN VIII), and critical autonomic centers controlling heart rate and respiratory drive. The close anatomical relationship between the brainstem and the tentorium cerebelli means that rotational forces can generate stress at this boundary, and brainstem dysfunction explains some of the most serious concussion symptoms: alteration of consciousness, autonomic dysregulation, and oculomotor disturbances. The cerebellum, with its role in motor coordination, balance, and timing, is a central structure in post-concussion vestibular and balance complaints; disruption of cerebellar-vestibular circuits produces the characteristic ataxia and dizziness that are assessed formally in tools like the SCAT6.

White Matter Tracts and Their Role

White matter constitutes approximately 50% of brain volume and is composed of myelinated axons that connect cortical and subcortical regions. In the context of concussion, white matter is the tissue of primary concern because its mechanical properties make it particularly vulnerable to shear injury under rotational acceleration.

The corpus callosum is subdivided anatomically into the rostrum (anterior-inferior), genu (anterior), body (middle), and splenium (posterior). Different regions carry different functional fiber populations: the genu interconnects prefrontal cortices (relevant to executive function), the body interconnects motor and premotor cortices, and the splenium interconnects parieto-occipital cortices involved in visuospatial processing. Diffusion tensor imaging (DTI) studies consistently demonstrate abnormalities in callosal white matter — particularly in the genu and body — following concussion, even when structural MRI is entirely normal. These DTI abnormalities reflect disruption of axonal microstructure detectable by changes in fractional anisotropy (FA) and mean diffusivity (MD), providing neuroimaging biomarkers of concussive injury even in the absence of macroscopic structural change.

The corona radiata is a fan-shaped array of white matter fibers that radiates from the internal capsule to the cortical mantle, carrying both ascending (sensory, thalamic) and descending (motor, corticospinal) projections. Because it has a broadly distributed geometry that is present throughout much of the cerebral hemisphere, it intercepts a wide range of shear trajectories and is frequently implicated in diffuse axonal injury (DAI) when angular forces are sufficient. The uncinate fasciculus, arcuate fasciculus, superior longitudinal fasciculus, and cingulum bundle are additional association tracts that are vulnerable to shear injury and whose disruption can explain specific neuropsychological deficits seen post-concussion — language processing difficulties, memory encoding problems, and disrupted emotional regulation, respectively.

Neuronal Ultrastructure: The Axonal Cytoskeleton

To understand the microscopic mechanism of concussive brain injury — particularly diffuse axonal injury — it is necessary to understand the internal architecture of the axon, specifically the cytoskeletal framework that maintains axonal integrity and supports the bidirectional transport of organelles, proteins, and vesicles along the axon’s length.

Microtubules are hollow cylindrical polymers of α/β-tubulin dimers (25 nm diameter) that run longitudinally along the axon and serve as the primary “railroad tracks” for axonal transport. Kinesin motor proteins carry cargo anterogradely (from cell body toward terminal); dynein carries cargo retrogradely (from terminal toward cell body). Tau protein — a microtubule-associated protein (MAP) — stabilizes microtubules by binding along their outer surface, promoting polymerization and preventing depolymerization. Under pathological conditions, tau becomes hyperphosphorylated (p-tau), reducing its affinity for microtubules, causing their destabilization and disassembly, and allowing tau to aggregate into paired helical filaments — the biochemical substrate of chronic traumatic encephalopathy (CTE) neuropathology.

Alpha-II spectrin is a cytoskeletal protein that links the actin cortex to the axonal plasma membrane and plays a critical role in maintaining axonal mechanical integrity. Under conditions of mechanical strain and calcium influx, the protease calpain cleaves spectrin at specific sites, generating the 150 kDa and 145 kDa spectrin breakdown products (SBDP150, SBDP145). This cleavage is an early marker of calcium-mediated axonal injury and has been studied as a potential CSF biomarker of concussion severity. Together, the disruption of neurofilaments, microtubules, tau, and spectrin under mechanical loading creates the ultrastructural substrate from which the macroscopic phenomena of impaired axonal transport, axonal swelling, and eventual axotomy develop over hours to days following concussion.

Chapter 2: Biomechanics of Head Injury

Forces, Accelerations, and the Brain

The mechanical events that cause concussion have been studied intensively since the mid-twentieth century, driven by both fundamental scientific interest and practical imperatives in helmet design, vehicle safety, and sports regulation. Understanding the biomechanics of head injury requires distinguishing between different types of mechanical input, understanding how brain tissue responds to mechanical loading, and appreciating the anatomical constraints that determine where injury occurs within the brain under different loading conditions.

The relative importance of translational versus rotational acceleration in producing concussion has been debated since Albert Holbourn’s landmark 1943 paper in The Lancet, in which he used gelatin models to argue that rotational rather than translational acceleration is the primary cause of white matter shear injury in the brain. Holbourn’s reasoning rested on the fact that the brain, like most biological tissues, is nearly incompressible — it behaves as a fluid with respect to volume change under hydrostatic (uniform) pressure. This means that purely translational loading, which generates uniform pressure across the brain, produces very little internal deformation; the brain simply moves as a unit. Rotational acceleration, by contrast, generates shear stresses — forces acting tangentially within the tissue — because different parts of the brain are accelerated to different velocities, and the tissue must deform internally to accommodate these velocity gradients. Holbourn estimated that rotational acceleration might account for as much as 90% of the brain deformation relevant to injury, a figure that modern biomechanical research has broadly supported, though with important nuances.

The axis of rotation matters critically. Rotation in the sagittal plane (flexion-extension, or anterior-posterior rotation) is particularly associated with diffuse axonal injury and concussion because it places maximum shear stress on the midbrain, corpus callosum, and superior brainstem — areas with high axonal density and high functional importance. Rotation in the coronal plane (lateral bending) generates shear at the parasagittal cortex and the lateral aspects of the corpus callosum. Rotation in the axial plane (horizontal rotation) is generally considered less injurious for a given magnitude because the brain’s roughly symmetric oval geometry in this plane distributes shear more evenly. In practice, most real-world concussions involve complex oblique accelerations that combine components from all three planes, but the sagittal-plane rotational component is most often implicated in the most severe functional consequences.

Brain Tissue Mechanical Properties

Brain tissue is a viscoelastic material, meaning that its mechanical behavior depends on both the magnitude of applied strain and the rate at which that strain is applied. A viscoelastic material combines properties of an elastic solid (which stores energy and returns to its original shape after deformation) and a viscous fluid (which dissipates energy during deformation, with the resisting force depending on strain rate rather than strain magnitude). The significance of viscoelasticity for concussion biomechanics is profound: brain tissue is far stiffer and stronger at high rates of loading (such as occur during collision-sport impacts) than at low rates of loading. This rate dependence means that injury thresholds cannot be described by a single stress or strain value — they depend on the temporal profile of the loading event.

The shear modulus of brain tissue at physiologically relevant strain rates has been measured in various experimental systems and ranges from approximately 0.5 kPa at quasi-static rates to several hundred kPa at the high strain rates characteristic of impact events. White matter is anisotropic — its mechanical properties differ depending on whether loading is applied parallel to or perpendicular to the axon axes — with higher stiffness and strength along the axon direction. This anisotropy means that shear strains applied transverse to axon bundles are particularly injurious, explaining why white matter tracts like the corpus callosum and corona radiata, which run in organized fascicles, are preferentially damaged by rotational loading.

Injury Criteria and Tolerance Curves

The challenge of quantifying when mechanical loading is sufficient to produce brain injury has occupied biomechanical researchers for decades and has generated several empirical and semi-empirical injury metrics.

The HIC emerged from automotive safety research and was designed primarily to predict skull fracture and focal brain injury (contusion, epidural/subdural hematoma) rather than diffuse axonal injury or concussion. Its emphasis on translational acceleration and its neglect of rotational components make it a poor predictor of concussion risk in sports, where rotational acceleration is the dominant mechanism. More recent injury criteria developed specifically for concussion in sports — such as the rotational injury criterion (RIC) and combined metrics like the Head Impact Power (HIP) model — attempt to incorporate rotational acceleration and the specific vulnerability of brain regions to shear.

The Wayne State Tolerance Curve, developed in the 1960s by Gurdjian and colleagues, plotted combinations of acceleration magnitude and duration associated with unconsciousness (used as a proxy for severe concussion) across a range of impact conditions. The curve revealed a hyperbolic relationship between acceleration magnitude and permissible duration: high accelerations are tolerable only for very brief durations, while lower accelerations can be sustained for longer periods without causing injury. This inverse relationship reflects the time-dependent nature of energy accumulation in the viscoelastic brain and has informed the design of impact attenuation requirements in helmet standards. The major limitation of the Wayne State Curve is that it was derived primarily from animal experiments and cadaveric studies and used gross neurological dysfunction (LOC) as the injury endpoint — arguably a severe endpoint relative to the subtler physiological disruption that constitutes concussion.

Modern in vivo biomechanical data from wearable sensor arrays (such as the Head Impact Telemetry, or HIT, system) have attempted to establish concussion thresholds empirically in American football players. Studies using the HIT system suggested that concussive impacts in collegiate football players involve mean peak linear accelerations of approximately 100 g and mean peak rotational accelerations of approximately 5,600 rad/s², though there is enormous overlap between concussive and sub-concussive impacts, and no single threshold reliably discriminates concussion from no concussion at the individual level. This overlap — combined with evidence that cumulative sub-threshold impacts may be biologically meaningful — has complicated the search for a simple biomechanical injury criterion and shifted scientific attention toward cumulative exposure metrics.

Finite Element Models of Brain Deformation

Finite element (FE) modeling applies the principles of continuum mechanics to the brain by dividing the organ into thousands of small volumetric elements, assigning material properties to each element, and numerically solving the equations of motion to predict stress, strain, and strain rate distributions throughout the brain under specified loading conditions. FE models of the human brain have become increasingly sophisticated, incorporating anatomically realistic geometries derived from MRI, region-specific material properties for gray and white matter, separate representations of the scalp, skull, meninges, CSF, and ventricular system, and increasingly, the anisotropic properties of white matter derived from DTI fiber tracking.

FE models have provided several important insights into concussion biomechanics. First, they consistently demonstrate that maximum shear strains occur not at the site of impact but in deep white matter structures — particularly the corpus callosum, internal capsule, and brainstem — where tissue heterogeneity creates stress concentrations. Second, they show that the CSF layer plays a meaningful energy-attenuating role by distributing impact energy across the brain surface, but that this attenuation is insufficient to prevent deep white matter strains at the impact magnitudes characteristic of concussive events. Third, FE simulations of reconstructed real-world concussions have validated the general prediction that rotational acceleration is the dominant driver of white matter shear strain, consistent with Holbourn’s original argument.

Helmet Attenuation Principles

Helmets protect the brain through two primary mechanisms: preventing skull fracture by distributing impact force over a larger area and longer time (thereby reducing peak force), and attenuating the peak linear acceleration transmitted to the head. Modern helmet liners — whether expanded polystyrene (EPS) foam in hard-shell helmets or softer polyurethane foams in softer designs — attenuate acceleration by deforming progressively under load, converting kinetic energy into heat through viscous deformation. The key engineering parameter is the balance between foam stiffness and liner thickness: stiffer, thinner liners bottom out (fully compress) at lower impact energies and then transmit impact energy directly to the skull, while softer, thicker liners spread deceleration over a longer time, reducing peak acceleration but requiring sufficient thickness to prevent bottoming-out.

The Virginia Tech STAR (Summation of Tests for the Analysis of Risk) rating system, developed by Stefan Duma and colleagues, rates helmets based on the expected number of concussions per unit of helmet use, derived from laboratory impact testing across a matrix of impact locations and severities weighted by the epidemiological frequency of each impact type observed from HIT sensor data in collegiate football. Unlike binary pass/fail standards (such as NOCSAE — the National Operating Committee on Standards for Athletic Equipment), STAR provides a continuous risk score that enables consumers and teams to compare helmets quantitatively. The system has identified substantial differences in concussion risk across commercially available helmets — even among models that meet identical NOCSAE certification standards — demonstrating that certification to a minimum standard does not equate to optimal concussion protection.

Chapter 3: Neurometabolic Cascade of Concussion

Overview of Post-Injury Physiology

The neurometabolic cascade of concussion, first synthesized by Giza and Hovda (2001) and subsequently refined through experimental and clinical research, provides the mechanistic foundation for understanding why concussion produces its characteristic clinical features and why recovery takes the time it does. The cascade describes a sequence of ionic, metabolic, vascular, and cellular events that unfold over minutes to hours to days following the initial mechanical insult. Crucially, many of these events are not harmful in isolation — they are normal physiological responses to membrane perturbation — but their temporal convergence creates a state of neural vulnerability that predisposes the injured brain to worsened outcomes from even minor subsequent perturbation during the window of metabolic crisis.

The cascade begins at the moment of mechanical impact, when abrupt membrane deformation — caused by shear strains traversing neural tissue — opens mechanosensitive ion channels and disrupts the normal electrochemical gradients maintained across neuronal membranes. This membrane perturbation triggers a cascade that is fundamentally energetic in nature: the brain expends massive amounts of energy trying to restore ionic homeostasis, but the very processes needed to do so are compromised by the injury, creating a bioenergetic mismatch — energy demand exceeds energy supply — that defines the acute vulnerability window.

Ionic Flux: The Initiating Event

The mechanical deformation of the neuronal membrane causes nonselective pore formation and disrupts the normal activity of voltage-gated and ligand-gated ion channels. The immediate consequence is a massive and largely indiscriminate ionic flux across the neuronal membrane. Potassium ions (\(\text{K}^+\)), which are maintained at high intracellular concentrations under normal conditions, flood outward down their concentration gradient, causing extracellular potassium concentration ([K⁺]out) to rise dramatically — from the normal 3 mEq/L to levels that may exceed 50–80 mEq/L in the peri-injury region. This rise in extracellular potassium causes widespread neuronal depolarization, triggering the release of excitatory amino acid (EAA) neurotransmitters.

Simultaneously, sodium ions (\(\text{Na}^+\)) and calcium ions (\(\text{Ca}^{2+}\)) flood inward down their electrochemical gradients. The influx of \(\text{Na}^+\) contributes to cellular swelling (cytotoxic edema) as water follows osmotically, while the influx of \(\text{Ca}^{2+}\) initiates a separate and particularly damaging cascade of calcium-mediated intracellular events described below. The net ionic disruption — potassium efflux combined with sodium and calcium influx — represents the immediate aftermath of the biomechanical insult and sets the stage for all subsequent pathophysiology.

Glutamate Excitotoxicity and NMDA Receptor Activation

The rise in extracellular potassium and the generalized membrane depolarization caused by the ionic flux trigger widespread release of glutamate — the brain’s principal excitatory neurotransmitter — from presynaptic terminals throughout the injured tissue. This massive glutamate release activates both AMPA (\(\alpha\)-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and NMDA (N-methyl-D-aspartate) receptors on postsynaptic membranes.

NMDA receptor activation is particularly important because NMDA channels are highly permeable to \(\text{Ca}^{2+}\), and their opening during excitotoxic states drives sustained calcium influx on top of the calcium entry occurring through voltage-gated calcium channels and through membrane pores created directly by the mechanical perturbation. The calcium that accumulates within the neuron initiates a series of destructive enzymatic processes. Calpains — calcium-activated proteases — are activated by elevated intracellular \(\text{Ca}^{2+}\) and cleave cytoskeletal proteins including spectrin, neurofilaments, and microtubule-associated proteins. Calpain-mediated spectrin cleavage produces characteristic breakdown products (SBDP150, SBDP145) detectable in CSF and, at lower concentrations, in blood. Phospholipases activated by \(\text{Ca}^{2+}\) degrade cell membrane phospholipids, releasing arachidonic acid and triggering inflammatory signaling. Nitric oxide synthase (NOS) activation by calcium produces nitric oxide, which at high concentrations generates peroxynitrite — a potent oxidizing agent that damages proteins, lipids, and DNA.

Na⁺-K⁺-ATPase Hyperstimulation and the Energy Crisis

The neuronal membrane Na⁺-K⁺-ATPase (sodium-potassium pump) is the primary engine of ionic homeostasis: it uses ATP hydrolysis to export three \(\text{Na}^+\) ions in exchange for importing two \(\text{K}^+\) ions, thereby maintaining the concentration gradients that power electrical signaling. Following the ionic disruption of concussion, the Na⁺-K⁺-ATPase is hyperstimulated as neurons attempt to restore normal ionic gradients. This dramatically increases the demand for ATP.

The brain’s primary fuel for ATP production is glucose, oxidized through glycolysis (in the cytoplasm) and oxidative phosphorylation (in mitochondria). Under the acute energy demand of ionic restoration, the brain markedly increases its glucose utilization — a phenomenon documented by \(^{18}\)F-fluorodeoxyglucose positron emission tomography (FDG-PET) studies showing transiently elevated cerebral metabolic rate for glucose in the minutes to hours following concussion. However, this increased demand occurs at precisely the time when energy supply is compromised by two intersecting problems: cerebrovascular dysregulation reduces cerebral blood flow (CBF), limiting substrate delivery, and mitochondrial dysfunction impairs the efficiency of glucose oxidation.

The result of increased demand and decreased supply is a bioenergetic mismatch: the brain is simultaneously spending more ATP and producing less. This energy crisis is the physiological basis for the clinical reality that the concussed brain is in a state of heightened vulnerability. A second insult — even one that would be trivial in a non-concussed brain — can push the energy-depleted tissue past its threshold of irreversible dysfunction, which is the proposed mechanism of second impact syndrome in its most severe form. The energy crisis also explains the phenomenon of post-concussion fatigue: with limited ATP available, the brain must ration energy expenditure, reducing capacity for demanding cognitive and physical tasks and generating the profound tiredness that concussed patients consistently describe.

Cerebrovascular Dysregulation and Reduced Blood Flow

Under normal conditions, cerebral blood flow (CBF) is maintained constant across a range of systemic blood pressures through the process of cerebrovascular autoregulation — the ability of cerebral arterioles to dilate in response to decreased perfusion pressure and constrict in response to increased perfusion pressure, ensuring a steady brain blood supply of approximately 50 mL/100g/min in gray matter. Following concussion, autoregulation is transiently disrupted, and CBF actually decreases relative to baseline during the period of peak metabolic demand. This paradoxical uncoupling — increased metabolic demand coinciding with decreased blood flow — has been documented by multiple neuroimaging methods including ASL-MRI, BOLD fMRI, and PET.

The mechanisms underlying post-concussion CBF reduction include vasospasm (arteriolar constriction in response to locally released vasoactive substances including endothelin), sympathetic overdrive from disrupted autonomic neural regulation, and the electrophysiological phenomenon of cortical spreading depression — a slowly propagating wave of neuronal depolarization and depression that occurs after various forms of brain injury and is associated with profound local CBF changes. The net effect is ischemia-like hypoperfusion in the context of hypermetabolic demand, substantially worsening the energy crisis. This CBF reduction is one of the reasons that rest — physical rest to avoid increasing systemic metabolic demands, and cognitive rest to avoid additional neural activation demands — has traditionally been recommended in the acute post-concussion period.

Calcium Accumulation and Diffuse Axonal Injury

The sustained accumulation of intracellular \(\text{Ca}^{2+}\) in concussed neurons and axons, driven by NMDA receptor activation, voltage-gated channels, and membrane disruption, is arguably the most consequential downstream event of the ionic cascade because it drives the pathophysiology of diffuse axonal injury (DAI).

Under conditions of calcium overload, axonal transport is disrupted at multiple levels. Calpain activation degrades neurofilament proteins and microtubule-associated proteins, destabilizing the tracks along which kinesin and dynein motor proteins operate. Microtubule depolymerization further impairs transport. The result is focal axonal swelling — the accumulation of transported materials (organelles, vesicles, proteins) at points where transport is blocked — producing the distinctive axonal varicosities or “axonal bulbs” that are the histological hallmark of DAI when seen on post-mortem or biopsy tissue. In living patients, the accumulation of amyloid precursor protein (APP) at sites of impaired axonal transport is the most reliable immunohistochemical marker of DAI; \(\beta\)-APP staining produces a characteristic punctate or beaded pattern along white matter tracts that can be detected within hours of injury.

The distinction between primary axotomy (immediate, mechanically-caused complete severance) and secondary axotomy (delayed, biochemically-mediated progressive dysfunction and eventual disconnection) is clinically significant because secondary axotomy is potentially reversible — if the calcium-driven cascade is interrupted before permanent cytoskeletal failure occurs, the axon may recover function. This therapeutic window, lasting potentially hours to days, has motivated research into neuroprotective agents targeting \(\text{Ca}^{2+}\) entry, calpain activation, and mitochondrial dysfunction, though no pharmacological intervention has yet demonstrated clinical efficacy in concussion.

Chapter 4: Clinical Presentation and Sideline Assessment

The Symptom Complex of Concussion

Concussion produces a heterogeneous cluster of symptoms that reflect the distributed nature of the underlying neurophysiological disruption. No single symptom is pathognomonic of concussion — indeed, every symptom in the post-concussion symptom inventory also occurs in other conditions (migraine, anxiety, sleep deprivation, ADHD). The diagnosis is clinical, based on recognizing the pattern of symptoms following a plausible mechanism of injury, and it is made in the appropriate clinical context rather than through any single test or biomarker.

The symptom complex of concussion can be usefully organized into four clusters, though in practice these clusters overlap substantially and most concussed individuals present with symptoms across multiple domains. The somatic cluster includes headache (the most common symptom, present in 70–90% of concussed individuals), photophobia, phonophobia, nausea, vomiting, dizziness, and balance disturbance. The cognitive cluster includes feeling “foggy” or slowed, difficulty concentrating, memory problems, and mental fatigue. The emotional/affective cluster includes irritability, emotional lability, anxiety, and sadness. The sleep cluster includes insomnia, hypersomnia, difficulty falling asleep, and unrefreshing sleep. The vestibular/ocular cluster — increasingly recognized as a distinct domain — includes vertigo, dizziness, visual instability, convergence insufficiency, and saccadic dysfunction.

It is important to appreciate that the temporal evolution of symptoms is characteristic but variable. In most concussed athletes, symptoms emerge immediately or within minutes of injury, peak within the first 24–72 hours, and resolve over the following 7–14 days. However, a subset of patients — estimated at 10–30% depending on the population and definition used — experience symptoms persisting beyond the expected recovery window. In children and adolescents, the expected recovery window is longer than in adults, and symptom resolution taking 4 weeks or more is not uncommon. Female sex, history of prior concussion, premorbid anxiety or depression, and high initial symptom burden are among the factors that predict prolonged recovery.

Loss of Consciousness: What It Means (and Does Not Mean)

Loss of consciousness (LOC) has historically been considered the defining feature of concussion, and in the lay mind, a “knockout” is synonymous with a “real” concussion. However, contemporary understanding makes clear that this equation is both incorrect and clinically misleading. LOC occurs in only approximately 10% of sport-related concussions, and its absence does not imply lesser injury. Conversely, LOC does not reliably predict greater symptom burden, longer recovery, or worse long-term outcomes.

What LOC does tell us mechanistically is that the reticular activating system of the brainstem — the network of nuclei and their ascending projections responsible for maintaining consciousness — was sufficiently disrupted by the impact to cause a transient failure of arousal. This requires either a direct mechanical perturbation of brainstem structures or, more commonly, a sufficiently intense shear stress propagating through the diencephalon-brainstem transition zone during rotational acceleration. The fact that LOC is brief (typically seconds to a few minutes in concussion, by definition less than 30 minutes) and self-limited reflects the functional, rather than structural, nature of this disruption in the concussion context.

What makes LOC a poor prognostic indicator specifically in the context of distinguishing “worse” from “better” concussions is the observation that many severely symptomatic concussions — those with prolonged cognitive impairment, weeks of disability, and high risk of persistent symptoms — occur without any LOC. The pathophysiology of extended disability relates to the extent and location of neurometabolic disruption (particularly involvement of prefrontal-limbic and vestibulo-ocular circuits) rather than to whether arousal was transiently suppressed. A concussion involving extensive disruption of vestibulo-cerebellar circuits might produce weeks of incapacitating dizziness without any LOC, while a concussion causing brief LOC might resolve completely within days. Clinicians and patients should therefore resist the temptation to calibrate expected recovery by the presence or absence of LOC.

The SCAT6: Sport Concussion Assessment Tool

The Sport Concussion Assessment Tool (SCAT) is the most widely used standardized sideline concussion assessment instrument globally, revised iteratively through the International Conferences on Concussion in Sport. The most current version, SCAT6, was introduced following the 2022 Amsterdam Consensus and reflects the latest evidence on assessment components, scoring, and cutoff values. It is designed for use by trained healthcare professionals in the acute (sideline) setting, not as a self-report tool or for use by non-clinicians.

The immediate memory component of the SCAT6 — part of the Standardized Assessment of Concussion (SAC) — requires the athlete to immediately repeat a list of 10 words after a single presentation (Word List A or B), and then recall that same word list after a 5-minute delay (delayed recall). This dual-phase assessment probes both working memory/encoding capacity and delayed recall, providing a brief but sensitive index of hippocampal-frontal memory function. A significant reduction from pre-season baseline in either immediate or delayed recall — or absolute scores falling below normative cutoffs — strongly supports the diagnosis of concussion. The SAC also includes orientation questions (day, month, date, year, day of week), which are sensitive to the acute confusional state that sometimes follows concussion.

The symptom inventory requires the athlete to rate 22 symptoms on a 7-point Likert scale (0 = none, 6 = severe), producing both a symptom count and a total symptom severity score. The inventory spans all four symptom clusters, providing a quantitative snapshot of symptom burden that can be tracked serially over recovery. In interpreting the inventory, both the number of symptoms and their severity matter; athletes with multiple moderate symptoms may be as impaired as those with fewer but more severe symptoms. Like all components of the SCAT6, the symptom inventory is most informative when baseline data are available, because some athletes report subclinical symptoms at baseline related to non-concussion conditions.

The Balance Error Scoring System (BESS) — the balance assessment component of the SCAT6 — evaluates postural stability by having the athlete perform three stances (double leg, single leg, tandem) on two surfaces (firm floor and a piece of medium-density foam), for a total of six conditions each held for 20 seconds. Errors are counted for each condition: opening eyes, lifting hands off hips, stepping, stumbling, falling, lifting forefoot or heel, moving the hip more than 30 degrees into flexion or abduction, or remaining out of position for more than 5 seconds each constitutes one error. Total errors across the six conditions constitute the BESS score, with higher scores indicating poorer balance. The firm-surface conditions primarily challenge the somatosensory system, while the foam-surface conditions challenge vestibular function by degrading somatosensory feedback. Post-concussion BESS scores are typically elevated (more errors) compared to baseline, reflecting disruption of vestibular, cerebellar, and proprioceptive integration.

The tandem gait task requires the athlete to walk heel-to-toe in a straight line over a prescribed distance (approximately 3 meters), turn 180 degrees, and return, with the time to complete the task recorded across four trials. Slower tandem gait times following concussion reflect impaired cerebellar-vestibular coordination and altered motor control. Like BESS, tandem gait is best interpreted relative to baseline, as there is substantial inter-individual variability in normal performance. The addition of tandem gait to the SCAT6 was motivated by evidence that timed gait tasks have better sensitivity and reliability than BESS alone.

Chapter 5: Diagnosis and Objective Assessment

Neuropsychological Testing

Neuropsychological assessment provides objective, standardized measurement of cognitive domains that are subjectively impaired in concussion — processing speed, attention, working memory, and reaction time — reducing reliance on symptom self-report, which is subject to effort, motivation, and reporting bias. In concussion management, neuropsychological testing serves both diagnostic and prognostic functions: it documents the cognitive deficit at the time of injury, provides an objective recovery endpoint distinct from symptom resolution, and may reveal persistent dysfunction in individuals who have become symptom-free but whose cognitive performance remains below baseline.

The ImPACT battery, administered over approximately 25 minutes, derives its composite scores from a series of subtests. The verbal memory composite reflects performance on word discrimination tasks; the visual memory composite reflects accuracy on design memory tasks; the processing speed composite reflects speed across symbol matching, color matching, and three-letter recall tasks; and the reaction time composite reflects mean reaction time across multiple stimulus-response paradigms. The impulse control score reflects the number of premature responses and is an internal validity indicator — high impulse control scores may indicate invalid performance due to inadequate effort or very rapid, inattentive responding. When interpreting ImPACT post-injury, clinicians typically compare the athlete’s scores to their own pre-season baseline rather than to normative data, because baseline scores vary considerably across individuals.

Cogstate is an alternative computerized cognitive battery with somewhat simpler cognitive demands (detection, identification, one-back working memory, and learning tasks), making it better suited to acute sideline assessment and to populations with limited computer familiarity. Like ImPACT, Cogstate generates reaction time and accuracy composites from response latency to playing-card stimuli. A key advantage of Cogstate is that it has been validated in multiple languages and populations and has documented sensitivity to acute concussion-related cognitive change in several prospective studies. Neither ImPACT nor Cogstate should be used in isolation as a diagnostic tool for concussion; both are best understood as components of a multimodal assessment battery.

Vestibular Assessment

Vestibular dysfunction is present in a majority of concussed athletes, reflecting disruption of the complex neural circuits integrating vestibular, visual, and somatosensory signals for the perception of spatial orientation and the stabilization of gaze during head movement. Clinical vestibular assessment examines the integrity of these circuits at multiple levels.

Clinical tests of VOR include the Head Impulse Test (HIT), in which the examiner rapidly rotates the patient’s head in the horizontal plane while the patient fixates on a stationary target, and notes whether a corrective “catch-up” saccade is required to re-acquire the target (indicating reduced VOR gain). Dynamic Visual Acuity (DVA) is a more functional VOR test that measures the reduction in visual acuity when the patient reads a standardized optotype chart during sinusoidal head oscillation at 2 Hz, compared to static visual acuity. A DVA loss greater than 2 lines on the logMAR chart is considered clinically significant and indicates VOR insufficiency. The Vestibular/Ocular Motor Screening (VOMS) tool, developed specifically for concussion assessment, includes five components: smooth pursuit, horizontal and vertical saccades, near point of convergence (NPC), horizontal VOR, and visual motion sensitivity (VMS), with symptom provocation during each task scored on a 0–10 scale.

Oculomotor Assessment

The oculomotor system — comprising smooth pursuit, saccadic, and vergence subsystems — is frequently disrupted following concussion because these functions depend on circuits traversing the frontal eye fields, superior colliculus, brainstem gaze centers (PPRF, nucleus prepositus hypoglossi, interstitial nucleus of Cajal), and cerebellum. Post-concussion oculomotor dysfunction is clinically important both as a diagnostic indicator and as a target for rehabilitation.

Smooth pursuit is assessed by having the patient track a slowly moving target with the eyes while the head remains still. Normal smooth pursuit is smooth and conjugate; post-concussion smooth pursuit is characterized by catch-up saccades — brief, rapid eye movements that interrupt the smooth tracking trajectory to re-acquire a target that the pursuit system failed to follow adequately. Saccade assessment examines the latency, velocity, and accuracy of rapid eye movements between targets. Post-concussion saccades may show increased latency (reflecting frontal eye field dysfunction), increased error (dysmetria, reflecting cerebellar involvement), or increased variability.

Convergence insufficiency post-concussion is diagnostically important for several reasons. It produces symptoms of near-vision blur, diplopia at near distances, and eye strain with reading or screen use — symptoms that heavily impact academic performance in student-athletes. It is sufficiently common and measurable that NPC measurement has been proposed as an objective concussion screening tool, though its sensitivity and specificity as a standalone diagnostic criterion remain subjects of active investigation. Evidence for rehabilitation-responsive convergence insufficiency supports vision therapy as a component of multimodal post-concussion rehabilitation.

Advanced Neuroimaging

Conventional structural neuroimaging — CT and standard T1/T2-weighted MRI — is characteristically normal following concussion by definition. CT is obtained acutely primarily to rule out structural complications: epidural or subdural hematoma, subarachnoid hemorrhage, cerebral contusion, and skull fracture. The decision to obtain CT in the acute setting is guided by validated clinical decision rules such as the Canadian CT Head Rule and the NEXUS II Criteria, which incorporate factors such as GCS score, age, mechanism of injury, vomiting, headache severity, and anticoagulant use. Advanced neuroimaging techniques, by contrast, can detect subtle microstructural and functional abnormalities not visible on conventional imaging.

Functional MRI (fMRI) using the blood-oxygen-level-dependent (BOLD) contrast mechanism measures neural activity indirectly by detecting changes in the ratio of oxygenated to deoxygenated hemoglobin in the cerebral vasculature. Task-based fMRI studies in concussed athletes have demonstrated altered patterns of neural activation during working memory tasks — typically showing either reduced activation in task-relevant regions (suggesting reduced neural efficiency) or paradoxically increased activation (potentially reflecting compensatory recruitment of additional neural resources). Resting-state fMRI examines the spontaneous fluctuations in BOLD signal across brain regions in the absence of any task, revealing functional connectivity networks (such as the default mode network, the salience network, and the frontoparietal network). Post-concussion disruptions in resting-state network connectivity — particularly in the default mode network — have been associated with cognitive symptom severity.

Magnetic resonance spectroscopy (MRS) measures the concentration of specific metabolites within a defined brain voxel by exploiting the unique resonance frequencies of different chemical bonds in a magnetic field. In concussion, MRS has demonstrated: decreased N-acetylaspartate (NAA, a marker of neuronal mitochondrial function), decreased choline (a marker of membrane turnover), increased glutamate/glutamine ratios (reflecting excitatory neurotransmitter excess), increased myo-inositol (a marker of glial activation), and elevated lactate (a marker of anaerobic metabolism). These MRS changes provide in vivo chemical evidence of the neurometabolic cascade described in Chapter 3, and longitudinal MRS studies have shown that metabolic recovery (as indexed by NAA normalization) often lags behind symptom resolution — a finding with important implications for return-to-play decisions.

Chapter 6: Pediatric Concussion

Developmental Neurobiology and Increased Vulnerability

The pediatric brain is not simply a smaller version of the adult brain; it differs in ways that are directly relevant to the mechanism, presentation, and recovery from concussion. Understanding these developmental differences is essential for appropriate management of concussion in children and adolescents, a population that may be at disproportionate risk for adverse outcomes following concussive injury.

Myelination of white matter tracts in the human brain is a prolonged developmental process that begins prenatally and continues well into the third decade of life. The last regions to complete myelination are the prefrontal cortex and the anterior corpus callosum — precisely the regions most critically involved in executive function, cognitive flexibility, and emotional regulation. Incomplete myelination in children and adolescents means that white matter is mechanically weaker (less stiff, more deformable) and metabolically more vulnerable than fully myelinated adult white matter. The myelin sheath, composed of lipid bilayers wrapped around the axon by oligodendrocytes, not only increases conduction velocity through the saltatory conduction mechanism but also provides mechanical protection, helping axons withstand transient deformation. In its absence or incomplete state, axons are more susceptible to both mechanical disruption from shear forces and to calcium-mediated damage following membrane perturbation.

The higher water content of the developing brain — reflecting the ongoing processes of synaptogenesis, dendritic arborization, and myelination — means that the tissue has different mechanical properties than adult brain: it is less stiff, more deformable, and may experience greater internal strains for a given head acceleration. The ratio of head size to neck muscle mass is also larger in children than in adults, meaning that the stabilizing capacity of the neck musculature is relatively lower and that the head is more freely accelerated by a given impact force — producing greater head acceleration for equivalent force compared to an adult.

The developing brain also lacks the neural reserve capacity of the mature brain. Neural reserve refers to the brain’s ability to compensate for focal disruption by recruiting alternative neural pathways, a capacity that depends on the richness of existing network connections and on the efficiency of existing neural architecture. Because the adolescent brain is still constructing these networks — pruning synapses, strengthening high-use connections, and myelinating high-priority tracts — there is less redundancy available to compensate when key circuits are disrupted. This reduced reserve capacity may partly explain the longer recovery trajectories consistently observed in pediatric concussion cohorts compared to adults.

Recovery Trajectories in Children and Adolescents

The expected recovery window for pediatric concussion is longer than for adults, with the evidence consistently showing that children and adolescents take approximately 4 weeks to recover, compared to approximately 1–2 weeks for the majority of adult athletes. The proportion of pediatric concussion patients who experience symptoms beyond 4 weeks ranges from 10% to 40% in different studies, depending on the population, the definition of “recovered,” and the follow-up method used.

Several factors specific to the pediatric context independently predict prolonged recovery. A prior concussion history — particularly a concussion occurring within the previous 12 months — is one of the strongest predictors of prolonged recovery in pediatric patients, consistent with the window of neural vulnerability described in Chapter 3 and with cumulative disruption of neural circuit integrity. Pre-existing anxiety and depression, which are common in adolescents, substantially increase the risk of symptom prolongation, both because anxious or depressed individuals may have lower symptom thresholds and may engage in hypervigilant symptom monitoring, and because anxiety and depression may share neurobiological substrates (HPA axis dysregulation, serotonergic dysfunction) with the post-concussion state, creating additive symptom burdens. Female sex is associated with longer recovery in most pediatric studies, a finding discussed in more detail in the special populations chapter.

Second Impact Syndrome

Second impact syndrome (SIS) is a rare but potentially catastrophic condition in which an individual sustains a second concussive injury before recovering fully from a first concussion. Although the rarity of SIS makes definitive epidemiological characterization challenging, case series — predominantly from adolescent American football players — have documented rapid neurological deterioration (within minutes of the second impact), diffuse cerebral swelling, herniation, and high rates of mortality or severe neurological disability. Most documented SIS cases have involved the pediatric population, leading to the hypothesis that the developing brain is specifically vulnerable to this phenomenon.

The proposed mechanism of SIS involves the neurometabolic vulnerability that persists after the initial concussion: the ionic disruption, mitochondrial dysfunction, and impaired cerebrovascular autoregulation of the acute post-concussion period mean that even a mild second impact can trigger a far more severe and poorly controlled physiological response than the same impact would produce in an uninjured brain. Catecholamine release at the moment of the second impact is hypothesized to cause vasodilation in a cerebrovascular system that has lost its normal autoregulatory capacity, leading to uncontrolled cerebral hyperemia. The resulting brain swelling progresses rapidly, raising intracranial pressure and potentially causing brainstem herniation through the tentorial notch or foramen magnum. The rapidity of deterioration — often minutes rather than hours — distinguishes SIS from slower-developing epidural or subdural hematomas.

It is important to acknowledge that SIS remains controversial in parts of the neurological community, primarily because the pathophysiology is inferred from case series without definitive neuropathological confirmation in most cases, and because some cases attributed to SIS may have been severe single-impact injuries where the “first” injury was not actually causing ongoing metabolic vulnerability. Nevertheless, the clinical reality that a second brain injury during the recovery window can cause catastrophically disproportionate harm is the strongest rationale for strict return-to-play protocols requiring complete symptom resolution before return to contact sport — particularly in the pediatric context.

Return-to-Learn Protocol

The return-to-learn (RTL) protocol addresses the cognitive demands placed on students by academic work and provides a graduated framework for re-engaging with school activities during concussion recovery. Cognitive activity — particularly activities requiring sustained attention, working memory, and executive processing — can exacerbate concussion symptoms, and early full academic re-engagement is not recommended. However, complete cognitive rest beyond the first 24–48 hours is also not supported by evidence and may be counterproductive by increasing social isolation, anxiety, and kinesiophobia.

The return-to-learn framework proceeds through five sequential steps, each requiring symptom tolerance at the current level before advancement to the next. Step 1 is complete rest — typically 24–48 hours of cognitive and physical rest — followed by Step 2, which involves light cognitive activity at home (reading short passages, watching television briefly) that does not significantly worsen symptoms. Step 3 involves return to school part-time with academic accommodations (reduced workload, extended time, reduced testing, note-taking assistance). Step 4 represents return to full school attendance with ongoing accommodations as needed. Step 5 is full academic activities without accommodations, signaling cognitive recovery. Communication between the healthcare provider, school personnel, and parents is essential to implement appropriate accommodations and to monitor for symptom exacerbation during academic re-engagement.

Chapter 7: Recovery and Return to Sport

The Berlin/Amsterdam Graduated Return-to-Sport Protocol

The graduated return-to-sport (GRTS) protocol, first formalized in the 2012 Zurich Consensus Statement and refined through subsequent Berlin (2017) and Amsterdam (2023) statements, provides the operational framework for returning concussed athletes to full sport participation in a safe, systematic manner. The protocol consists of six sequential steps, with the overarching principle that each step must be completed without symptom exacerbation before advancement to the next, and that any return of symptoms requires stepping back to the previous step for at least 24 hours before reattempting advancement.

Step 1 is complete rest — no physical or cognitive exertion — and typically lasts only the first 24–48 hours post-injury. Prolonged complete rest (beyond 1–2 days) is not recommended based on emerging evidence that it may impede recovery and increase psychological distress. The rationale for even brief rest is to allow the acute phase of the neurometabolic cascade to begin resolving without additional energy demands compromising the bioenergetically vulnerable tissue. Step 2 is light aerobic exercise: walking, swimming, or stationary cycling at low intensity, with no resistance training. The physiological rationale is that light aerobic exercise increases cerebral blood flow, which has been shown to be reduced post-concussion, without placing demands that would exceed the recovering brain’s energy supply. Heart rate should remain below the symptom threshold (determined through formal exertion testing if possible).

Step 3 involves sport-specific exercise — skating drills in hockey, running patterns in football — that adds coordination demands and sport-specific movement patterns to the aerobic base established in Step 2. Head impact exposure remains prohibited at this stage; no contact, collision, or impact is allowed. Step 4 introduces non-contact training drills, including practice with teammates, complex drills, resistance training, and skill-specific training, but still no head impact. Step 5 is full contact practice following medical clearance — this is the critical step because it reintroduces the athlete to the risk of head impact and should not be attempted until all symptoms have resolved, baseline neuropsychological testing has been restored, and medical clearance has been obtained from a physician. Step 6 is unrestricted return to competition.

Physical and Cognitive Rest: Evidence for Early Mobilization

The traditional recommendation of strict cognitive and physical rest — often expressed to patients as “cocoon therapy” — has been substantially revised in light of emerging evidence. The 2023 Amsterdam consensus statement explicitly discourages prolonged strict rest beyond the initial 24–48 hours and supports the early introduction of sub-symptom-threshold aerobic exercise as part of a proactive management approach. The rationale for this shift comes from several converging lines of evidence.

First, randomized controlled trial evidence — most notably the study by Leddy and colleagues comparing the Targeted Heart Rate Aerobic Training (THRAT) protocol to a stretching-only control — demonstrated that early sub-threshold aerobic exercise, initiated within 10 days of injury and titrated to remain below the heart rate that provokes symptoms (the symptom threshold heart rate), significantly shortened recovery duration in adolescents with concussion compared to strict rest. The mechanism appears to involve restoration of cerebrovascular regulation and cerebral blood flow autoregulation that are disrupted post-concussion. Second, observational studies have demonstrated that athletes who are kept on strict rest for prolonged periods develop deconditioning, increased psychological distress, and in some cases, exercise intolerance — a pattern that may contribute to persistent post-concussion symptoms through a cycle of symptom anticipation, physical deconditioning, and orthostatic intolerance.

Buffalo Treadmill Protocol

The Buffalo Concussion Treadmill Test (BCTT) is a sub-symptom-threshold aerobic exercise test developed by Leddy, Willer, and colleagues that serves both as a diagnostic tool (to objectively identify the symptom threshold heart rate and confirm physiological exercise intolerance) and as a therapeutic framework (to guide the target heart rate for subsequent aerobic exercise prescription).

In practice, the BCTT begins at a slow walking pace and increases speed by 0.5 mph every minute while treadmill incline increases gradually. Symptom ratings are obtained at each stage, and the test terminates when symptoms worsen by 3 or more points or when the athlete reaches predicted maximum heart rate without symptom provocation. Athletes who complete the test symptom-free are considered to have passed (negative test), indicating normal physiological response to aerobic exercise and suggesting that exercise intolerance is no longer a barrier to GRTS progression. Athletes who develop symptoms at a specific heart rate (positive test) receive an exercise prescription targeting 80–90% of the symptom threshold heart rate — a level theoretically sufficient to provide cerebrovascular conditioning benefits without provoking symptom exacerbation. The BCTT protocol has been validated in multiple studies and is now endorsed in the Amsterdam consensus as part of the clinical assessment and management framework for concussion.

Chapter 8: Persistent Post-Concussion Symptoms

Definition and Diagnostic Criteria

Persistent post-concussion symptoms (PPCS), also referred to in the literature as post-concussion syndrome (PCS), describes the clinical scenario in which concussion-related symptoms persist beyond the expected recovery window. The definition of this window varies across diagnostic systems: ICD-10 (International Classification of Diseases, 10th edition) defines PCS as symptoms persisting for at least 4 weeks following a “postconcussional syndrome” caused by a head injury, with specific required symptom types. DSM-5 uses the construct of “Major or Mild Neurocognitive Disorder Due to Traumatic Brain Injury” (NCD-TBI), which does not specify a minimum duration and focuses on objective cognitive decline, making it less applicable to the primarily symptomatic but cognitively subtle PPCS population.

The epidemiology of PPCS is complicated by the definitional heterogeneity described above, but most prospective cohort studies suggest that approximately 10–30% of adult athletes and 15–40% of pediatric patients fail to recover within the expected window. Risk factors for PPCS include female sex, age (both younger — pediatric — and older — middle-aged and elderly adults), prior concussion history, premorbid anxiety or depression, sleep disorders, history of migraine, learning disabilities, and ADHD. High initial symptom burden — particularly the number and severity of symptoms in the acute phase — is among the strongest predictors of prolonged recovery, consistent with the interpretation that more extensive initial neurometabolic disruption correlates with longer recovery time.

Symptom Subtypes and the Multimodal Rehabilitation Approach

The key insight driving contemporary PPCS management is that the condition is not a single entity but rather a heterogeneous syndrome composed of multiple distinct pathophysiological subtypes, each of which has specific clinical features and specific evidence-based treatments. Applying a single treatment approach to all PPCS patients — as was common when rest was the default management — fails most patients because it addresses only one potential driver of symptoms while ignoring others.

The cervicogenic subtype arises when injury to the cervical spine soft tissues at the time of the concussive event — whiplash-type strain of muscles, ligaments, and facet joint capsules — contributes to headache, neck pain, dizziness, and sometimes paresthesias. Cervicogenic symptoms are often overlooked because they overlap with primary concussion symptoms, but careful cervical spine examination (palpation for tenderness, assessment of active range of motion, upper cervical segmental mobility testing) reveals cervical involvement in a substantial proportion of PPCS patients. Treatment for the cervicogenic subtype focuses on cervical manual therapy, physiotherapy targeting cervical mobility and strength, and postural correction.

The vestibular subtype reflects disruption of the peripheral or central vestibular system, producing dizziness, vertigo, imbalance, and motion sensitivity. Approximately 30–80% of concussed individuals have some degree of vestibular dysfunction acutely, and in PPCS patients, vestibular involvement is among the most common findings. The specific vestibular pathology varies: benign paroxysmal positional vertigo (BPPV — see Chapter 9) involves canalith debris in the semicircular canals; central vestibular hypofunction reflects disruption of brainstem or cerebellar vestibular circuits; and vestibular migraine represents a distinct entity that may be triggered or exacerbated by concussion. Treatment is tailored to the specific vestibular diagnosis.

The oculomotor subtype features convergence insufficiency, saccadic dysfunction, smooth pursuit abnormalities, and accommodative dysfunction as the primary drivers of symptoms — particularly near-vision symptoms, reading difficulty, and visual fatigue. Vision therapy, administered by an optometrist or orthoptist with expertise in binocular vision, is the evidence-based treatment for this subtype (see Chapter 9).

The anxiety/mood subtype occurs when anxiety, depression, or post-traumatic stress disorder (PTSD) are the primary drivers of symptom persistence. In this subtype, the original neurometabolic injury may have resolved but psychological factors — catastrophizing, fear of re-injury, hypervigilant symptom monitoring, and mood disruption — amplify and perpetuate symptom experience. Cognitive behavioral therapy (CBT) is the primary evidence-based treatment, potentially supplemented by pharmacological management.

The cognitive/fatigue subtype features impaired cognitive processing speed, poor concentration, and profound mental fatigue as the dominant complaints. Cognitive rehabilitation targeting attention, working memory, and fatigue management strategies (pacing, energy conservation) is the primary intervention. The sleep subtype is characterized by sleep disturbance (insomnia, hypersomnia, or circadian disruption) as the primary maintaining factor, and responds to sleep-specific interventions (see Chapter 11).

Chapter 9: Vestibular Rehabilitation and Vision Therapy

Vestibular Physiology and BPPV

The vestibular system provides the brain with information about head position and motion through five peripheral sensory organs in the inner ear: three semicircular canals (superior, posterior, and horizontal) that detect angular acceleration, and two otolith organs (utricle and saccule) that detect linear acceleration and static head orientation relative to gravity. The semicircular canals are fluid-filled (endolymph) tubes arranged at approximately right angles to each other; head rotation in the plane of a canal generates endolymph flow that deflects the cupula (a gelatinous membrane) and stimulates hair cells at the base of the canal. The signals from both vestibular labyrinths are integrated in the vestibular nuclei of the brainstem and then distributed to multiple targets: the oculomotor nuclei (generating the VOR), the spinal cord (generating the vestibulosp inal reflex for postural control), and the thalamus and cortex (for conscious perception of motion and spatial orientation).

The physics of canalith repositioning — specifically the Epley maneuver for posterior canal BPPV (the most common variant) — is elegant. In posterior canal BPPV, otoconia have entered the posterior semicircular canal and move toward the ampulla (ampullofugal flow) when the head is positioned in the Dix-Hallpike test position, generating strong upbeat-torsional nystagmus. The Epley maneuver moves the patient’s head through a sequence of four positions designed to use gravity to roll the canalith debris out of the posterior canal, through the common crus, and into the utricle — where it no longer causes pathological cupular deflection. Each position is held for approximately 30 seconds to allow the debris to settle. A single Epley maneuver resolves symptoms in approximately 80% of posterior canal BPPV cases, with repeat treatments resolving the majority of remainder. For horizontal canal BPPV (the second most common variant), the barbecue roll (Lempert maneuver) is used instead.

Vestibular Hypofunction and Gaze Stabilization Exercises

When the vestibular dysfunction following concussion reflects central rather than peripheral pathology — disruption of vestibular processing in the brainstem or cerebellum rather than canal debris — canalith repositioning is ineffective and vestibular rehabilitation exercises targeting gaze stabilization and habituation are required. VOR × 1 exercises (gaze stabilization training) involve having the patient fix their gaze on a stationary target while moving the head in the yaw, pitch, or roll planes at increasing speeds, training the VOR to maintain gaze stability during head motion. Initially performed slowly and in small ranges of motion, the exercises progress in speed, amplitude, and complexity as the patient’s symptom tolerance and VOR gain improve.

VOR × 2 exercises are a more demanding variant in which the patient moves the target in the direction opposite to the head movement (head moves right, target moves left), doubling the retinal slip and demanding greater VOR gain. These exercises are appropriate for patients who have achieved adequate VOR × 1 tolerance and need greater challenge to continue improving. Gaze stabilization exercises have been shown in randomized trials to improve VOR gain, reduce dizziness, and improve functional balance in patients with chronic vestibular hypofunction. Their application in post-concussion vestibular rehabilitation is supported by expert consensus and case series data, though large RCT evidence specifically in concussion is still emerging.

Vision Therapy for Oculomotor Dysfunction

Vision therapy for concussion-related oculomotor dysfunction targets the specific deficits identified in assessment — convergence insufficiency, saccadic dysmetria, smooth pursuit errors, and accommodative dysfunction — through a structured program of exercises designed to improve the efficiency, accuracy, and endurance of the affected systems.

For convergence insufficiency, the foundational exercises are pencil push-ups (bringing a pencil slowly toward the nose while maintaining single binocular fixation for as long as possible before diplopia occurs, then repeating) and Brock string exercises (maintaining fusion on successive beads along a string while being aware of the physiological diplopia pattern that confirms correct binocular function). Base-out prism therapy uses prisms to impose additional vergence demand, gradually training the vergence system to converge more powerfully. Computer-based vergence therapy programs (such as HTS, the Home Therapy System) deliver randomized vergence challenges that are titrated to the patient’s current vergence capacity and progressed as convergence improves.

Saccade training exercises include the “Hart chart saccades” (rapidly alternating fixation between corresponding letters on two charts held at reading distance, building saccadic accuracy and speed), random saccade programs on tablets or computers, and in-office saccadic pursuit training under optometric supervision. Smooth pursuit training begins with slow, predictable target motion and progresses through higher speeds and less predictable trajectories. All vision therapy protocols are individualized to the patient’s specific profile of deficits and progress as objective measures (NPC, saccadic latency and accuracy, smooth pursuit gain) normalize.

Chapter 10: Depression, Mood, and Psychological Consequences

Prevalence and Pathophysiology of Post-Concussion Mood Disturbance

Depression and anxiety following concussion are among the most functionally significant and underappreciated consequences of the injury. Meta-analyses and systematic reviews consistently document that the prevalence of major depressive disorder in the post-concussion period is substantially elevated above population norms — with point prevalence estimates of 20–44% in clinical samples — and that depression significantly prolongs overall recovery by maintaining symptom hypervigilance, impairing motivation for rehabilitation, and disrupting sleep.

The pathophysiology of post-concussion depression is multifactorial and incompletely understood. Direct neurobiological mechanisms include disruption of the HPA (hypothalamic-pituitary-adrenal) axis, which regulates the cortisol stress response and is intimately linked to mood regulation. Animal models of mild TBI have demonstrated both acute cortisol hypersecretion (driven by the physiological stress of injury) and subsequent blunting of the HPA response — an “allostatic load” pattern — that may predispose to depressive states. Disruption of the serotonergic system is also implicated: concussive injury has been shown in animal models to reduce serotonin transporter (SERT) binding and 5-HT1A receptor density in limbic regions, reducing the functional capacity of the serotonergic system precisely in the regions — prefrontal cortex, anterior cingulate, hippocampus — most relevant to mood regulation.

Psychological mechanisms are equally important. The experience of concussion — an invisible injury that others cannot see, with symptoms that are inconsistent, unpredictable, and often dismissed by the medical and social environment — is inherently distressing. Athletes who define their identity through sport face profound identity disruption during the recovery period. The loss of physical activity, which is itself a powerful antidepressant through endorphin release, BDNF upregulation, and HPA axis modulation, removes a critical psychological coping resource precisely when it is most needed. Social isolation resulting from school absence, reduced sport participation, and cognitive limitation of social activities further amplifies mood vulnerability. The resulting picture in many concussed patients is one of genuine neurobiological mood disruption compounded by reactive psychological distress in response to a profoundly disruptive life experience.

Cognitive Behavioral Therapy and Pharmacological Management

Cognitive behavioral therapy (CBT) is the first-line psychological intervention for post-concussion anxiety and depression, with evidence from both the general mental health literature and the concussion-specific literature supporting its efficacy. CBT for post-concussion mood targets the unhelpful thought patterns that perpetuate symptom distress — catastrophizing (“my life is ruined,” “I’ll never recover”), hypervigilant symptom monitoring, and all-or-nothing thinking about activity — and replaces them with more balanced appraisals and graduated behavioral activation. Behavioral activation — the systematic re-engagement with valued activities, beginning with low-demand pleasurable activities and progressing — is particularly important because behavioral withdrawal (the natural response to symptoms) paradoxically maintains depression and perpetuates the deconditioning cycle.

Pharmacological management of post-concussion depression is indicated when symptoms are severe, when CBT access is limited, or when psychological symptoms are not responding adequately to non-pharmacological interventions within approximately 6–8 weeks. Selective serotonin reuptake inhibitors (SSRIs) — particularly sertraline and escitalopram, which have the best evidence in the general depression literature and the most favorable side-effect profiles — are the pharmacological agents of choice. The timing of pharmacological initiation requires clinical judgment: starting SSRIs very early (within the first week) is not routinely recommended for most patients, as the majority will recover without pharmacological intervention, and early SSRI use may complicate the attribution of recovery to the natural course versus medication. When SSRIs are indicated, they should be started at low doses and titrated slowly, as the concussed brain may be more sensitive to side effects including the temporary anxiety increase and sleep disruption that can accompany SSRI initiation.

Tricyclic antidepressants (particularly amitriptyline at low dose) have a role in managing post-concussion headache with a migraine phenotype — where their analgesic and prophylactic properties are useful — though their anticholinergic side effects and cognitive-loading properties limit their use in patients with significant cognitive symptoms. SNRIs may be appropriate for patients with comorbid anxiety and depression. Benzodiazepines are generally to be avoided in the post-concussion setting because of their effects on cognitive processing, sleep architecture, and physical balance that can confound assessment and potentially worsen neurological recovery.

Chapter 11: Sleep Disturbances After Concussion

Pathophysiology of Post-Concussion Sleep Disorders

Sleep disturbance is one of the most prevalent and burdensome symptoms following concussion, reported by approximately 50–80% of concussed individuals in the acute phase and persisting in a substantial proportion into the PPCS period. The disturbance takes several forms — insomnia (difficulty falling or staying asleep), hypersomnia (excessive sleep or sleepiness), and circadian rhythm disruption — each with distinct mechanisms and treatment implications.

Post-concussion insomnia is often driven by a combination of neurobiological and psychological mechanisms. At the neurobiological level, disruption of the hypothalamic circadian oscillator (the suprachiasmatic nucleus, SCN), thalamic arousal relay circuits, and brain-stem sleep-promoting nuclei (including the ventrolateral preoptic area, VLPO) by the neurometabolic cascade can disrupt the normal balance between sleep-promoting and wake-promoting systems. Pain — particularly headache — is a powerful insomnia-generating factor that many concussed patients experience. At the psychological level, anxiety about sleep, hyperarousal, and rumination create the classic psychophysiological insomnia pattern that perpetuates sleep difficulty long after any primary neurobiological disruption has resolved.

The mechanism of melatonin’s sleep-promoting effect is primarily chronobiotic (phase-shifting the circadian clock) rather than hypnotic — it works best when taken at consistent times relative to the desired sleep schedule, reinforcing the circadian signal that drives sleep onset. In the post-concussion setting, melatonin is preferred over sedative-hypnotics (benzodiazepines, “Z-drugs”) because it does not impair cognitive function, does not depress respiratory drive, and does not produce dependence. Doses used in the concussion context are typically lower than the very high doses available over the counter in North America (which are often 5–10 mg) — 0.5 to 3 mg is the physiologically appropriate range. Evidence from pediatric concussion populations (including the 2014 study by Barlow and colleagues) suggests that low-dose melatonin reduces sleep disturbance and may have a positive effect on overall symptom burden during recovery.

CBT-I and Sleep Hygiene

Cognitive behavioral therapy for insomnia (CBT-I) is the most effective treatment for chronic insomnia regardless of etiology, with effect sizes that exceed those of pharmacological interventions in direct comparisons and with effects that are more durable after discontinuation. In the post-concussion context, CBT-I is particularly important for patients in whom psychological perpetuating factors (conditioned arousal, sleep-related catastrophizing, dysfunctional beliefs about sleep) have become the primary drivers of insomnia, even if the original trigger was the concussion itself.

Core CBT-I components include sleep restriction therapy (limiting time in bed to the patient’s current actual sleep duration, then gradually expanding as sleep efficiency improves), stimulus control (restricting the bed to sleep and intimacy only, to reassociate the bed environment with sleepiness rather than wakefulness), sleep hygiene education, relaxation training, and cognitive restructuring of dysfunctional beliefs about sleep. Sleep hygiene principles — consistent sleep and wake times, avoidance of caffeine in the afternoon and evening, avoidance of bright light exposure in the evening, limitation of screen time before bed, cool bedroom temperature, and physical activity timing — provide a behavioral framework that supports but does not replace active CBT-I techniques in patients with established insomnia.

Chapter 12: Chronic Traumatic Encephalopathy (CTE)

Historical Context and Neuropathological Definition

Chronic traumatic encephalopathy is a progressive neurodegenerative disease associated with repetitive traumatic brain injury, most extensively studied in the context of contact sports (American football, boxing, hockey, rugby) and military blast exposure. The modern understanding of CTE traces directly to the work of neuropathologist Bennet Omalu, who in 2005 published the first autopsy case report of a neuropathologically confirmed CTE diagnosis in former Pittsburgh Steelers center Mike Webster — following dementia, depression, and behavioral deterioration that developed in Webster’s final years. Omalu’s findings, ultimately confirmed and expanded by Ann McKee’s group at Boston University’s CTE Center (UNITE Brain Bank), established CTE as a distinct neuropathological entity defined by the perivascular accumulation of hyperphosphorylated tau (p-tau) protein in specific anatomical patterns.

The neuropathology of CTE is defined by the McKee staging system (2013, revised 2021), which categorizes severity based on the extent and distribution of p-tau pathology across four stages. In Stage I, p-tau deposits are sparse and focal, concentrated in the perivascular regions of the superior frontal cortex, typically at sulcal depths. Stage II shows wider distribution of p-tau through the frontal and temporal lobes with involvement of the hippocampus. Stage III demonstrates widespread cortical p-tau deposition, hippocampal involvement, and beginning brainstem changes, with associated neuronal loss and white matter degeneration. Stage IV is the most severe, with extensive p-tau throughout the neocortex, deep nuclei (amygdala, hippocampus, hypothalamus, basal ganglia, and brainstem), massive neuronal loss, and severe white matter degeneration — a picture resembling a combination of Alzheimer’s disease and frontotemporal dementia at the macroscopic level, but with the distinctive perivascular and sulcal depth p-tau distribution that defines CTE neuropathologically.

TDP-43 Pathology and Molecular Mechanisms

Beyond p-tau, CTE brains consistently show accumulation of TDP-43 — TAR DNA-binding protein 43 — a nuclear RNA-binding protein that when pathologically mislocalized from the nucleus to the cytoplasm, aggregates and forms inclusions associated with neurodegeneration. TDP-43 pathology is also the hallmark of amyotrophic lateral sclerosis (ALS) and a subset of frontotemporal dementia (FTLD-TDP), raising the question of whether the ALS-like motor neuron disease observed in some former professional athletes (the “ALS-CTE” phenotype) represents CTE-associated TDP-43 pathology extending to motor neurons. Current evidence suggests that TDP-43 pathology in CTE is secondary to the primary tau-driven pathology but may contribute independently to clinical presentation, particularly cognitive and behavioral symptoms.

The mechanism by which repetitive traumatic brain injury generates the specific p-tau accumulation pattern of CTE is not fully understood, but leading hypotheses center on two intersecting processes. First, traumatic brain injury releases tau protein from disrupted axons into the extracellular space, where it can be taken up by adjacent neurons and act as a prion-like “seed” for templated aggregation — inducing normal tau in recipient neurons to adopt the pathological conformation and aggregate. This prion-like spread mechanism, now documented for tau in multiple neurodegenerative diseases, could explain the progressive, anatomically spreading character of CTE pathology after an initial triggering insult. Second, the neuroinflammatory response to traumatic brain injury — particularly the sustained activation of microglia and astrocytes — may create a chronic inflammatory milieu that drives ongoing tau phosphorylation through kinases including GSK-3β and CDK5.

Clinical Features and the Causality Debate

The clinical syndrome of CTE, to the extent it can be defined from autopsy series with retrospective clinical reconstruction, has been described in two phenotypic variants. The behavior/mood variant — associated predominantly with lower-stage pathology — is characterized by explosive or inappropriate behavior, emotional dysregulation, apathy, depression, and executive dysfunction emerging in middle age, often in someone who was functioning normally or near-normally in the years following retirement from sport. The cognitive variant — more commonly associated with higher-stage pathology and later onset — resembles a dementia syndrome with progressive memory impairment, executive dysfunction, and language difficulties.

The causal argument for CTE being associated with repetitive traumatic brain injury is supported by: the strong epidemiological association between contact sport participation and CTE neuropathology at autopsy, the dose-response relationship between years of contact sport play and CTE neuropathology severity seen in the UNITE Brain Bank data, the biological plausibility of the tau release-and-propagation mechanism, and the near-universal presence of CTE neuropathology in brains from individuals with very extensive contact sport histories (e.g., boxers and longtime NFL players). The causal argument is complicated by: the profound selection bias in all autopsy series (brains are submitted by families who observed behavioral/cognitive decline, systematically excluding former athletes who died without neurological symptoms), the absence of a validated in vivo biomarker that would allow prospective longitudinal studies without autopsy confirmation, the prevalence of co-occurring Alzheimer’s and other neurodegenerative pathologies that complicate CTE attribution, and the fact that CTE has been documented very rarely in the general population without clear contact sport or TBI history, raising questions about the specificity of the pathological pattern.

Biomarkers of CTE and Neurodegeneration

The absence of validated in vivo biomarkers for CTE has been the single greatest barrier to understanding its epidemiology, natural history, and causation. Without the ability to diagnose CTE in living individuals, prospective studies cannot be conducted and treatment cannot be developed. This gap has driven intensive research into blood and CSF biomarkers capable of detecting the pathological processes characteristic of CTE.

Plasma and CSF tau biomarkers — particularly phospho-tau at threonine-181 (p-tau181) and p-tau217 — have emerged from Alzheimer’s disease biomarker research as highly sensitive and specific markers of in vivo tau pathology. Elevated plasma p-tau181 and p-tau217 have been detected following acute single concussions, suggesting that even individual concussive events generate measurable tau release. Whether the pattern of p-tau elevation following repetitive traumatic brain injury can distinguish CTE pathology from Alzheimer’s pathology in living individuals remains an open research question. Neurofilament light chain (NfL) in plasma and CSF is an established biomarker of axonal damage and neurodegeneration broadly, with elevated levels documented following concussion and in neurodegenerative diseases; it lacks specificity for CTE but may serve as a marker of cumulative neurodegeneration burden. GFAP (glial fibrillary acidic protein) is a marker of astrocyte activation and glial injury that is elevated acutely after TBI and has shown promise as an early indicator of brain injury severity.

Chapter 13: Prevention of Concussion

Rule Changes and Policy Interventions

Prevention of concussion at the population level requires a multifaceted approach combining rule changes, equipment improvements, education, and culture change. Rule changes represent the highest-leverage intervention because they can reduce the frequency or severity of concussion-causing impacts across an entire population without requiring individual compliance with equipment or behavioral changes.

In ice hockey, the most extensively studied rule-based intervention is the age at which body checking is permitted. Canada’s Hockey introduced a rule change in 2011 raising the minimum age for body checking in minor hockey from peewee (11–12 years) to bantam (13–14 years). Prospective epidemiological studies — most prominently the work of Emery and colleagues at the University of Calgary — demonstrated that the rate of concussion in the first year following this policy change was approximately 67% lower in peewee-level players in provinces that implemented the ban compared to those that did not. This represents one of the most compelling examples of rule-change effectiveness in concussion prevention, demonstrating that delaying exposure to body checking significantly reduces concussion risk during a critical developmental period. The study also demonstrated that players in body-checking leagues who had not yet received the skill training necessary to both execute and receive checks safely were at disproportionate risk.

In American football, tackling technique restrictions — particularly the “heads-up football” initiative and the prohibition of “targeting” (leading with the crown of the helmet) — aim to reduce the frequency of high-severity impacts by changing the mechanism of contact. Evidence for the effectiveness of these interventions in reducing concussion rates is mixed, partly because technique changes at the practice level do not always persist under game-speed competitive conditions and partly because enforcement and measurement are difficult. Nevertheless, rule changes prohibiting the most dangerous tackling and blocking techniques are widely supported as sound policy on both biomechanical and ethical grounds.

Equipment Standards and Technology

Helmet standards govern the minimum performance requirements that helmets must meet before being certified for use in sport. In North America, the NOCSAE (National Operating Committee on Standards for Athletic Equipment) sets the certification standards for football, lacrosse, and hockey helmets, primarily through drop tests and pendulum impact tests that assess the helmet’s ability to attenuate linear acceleration to the head. NOCSAE standards use the HITS (Head Impact Telemetry System) probability threshold — currently requiring that the probability of skull fracture be reduced to less than 1% at a defined impact energy — as the primary endpoint.

The MIPS (Multi-directional Impact Protection System) technology directly addresses the limitation of conventional liner-only designs by attenuating rotational acceleration — the primary concussion-producing mechanism. MIPS incorporates a thin, lubricated shell (the MIPS “brain protection system”) between the helmet’s outer shell and inner comfort padding. When an oblique impact applies tangential force to the outer shell, the MIPS shell slides laterally by approximately 10–15 mm relative to the inner comfort liner, redirecting some of the rotational energy away from the head and reducing the rotational acceleration transmitted to the brain. Biomechanical laboratory testing has demonstrated 10–15% reductions in rotational acceleration with MIPS-equipped helmets compared to equivalent helmets without MIPS, across a range of impact angles. Whether these biomechanical improvements translate to clinically meaningful reductions in concussion incidence remains an active area of investigation, though the theoretical rationale is strong.

Mouthguards and Neck Strengthening

The evidence for mouthguards in concussion prevention has been debated for decades. The proposed mechanism is that a properly fitted mouthguard might absorb some impact energy delivered to the mandible before it is transmitted to the skull, thereby attenuating the acceleration of the cranial contents during certain impact types. Laboratory studies have shown mixed results regarding the degree of acceleration attenuation provided by mouthguards, and clinical epidemiological studies have not consistently demonstrated a significant protective effect against concussion in sports where mouthguard use is mandated versus optional. The current consensus is that mouthguards protect effectively against dental and orofacial injuries but have insufficient evidence supporting their role in concussion prevention.

Neck strength and head-neck kinematics represent a more biologically plausible modifiable risk factor for concussion. The physics are straightforward: for a given impact force applied to the head, a more massive “head-neck system” — effectively, the combined inertia of the head and the muscular resistance of the neck — will undergo less acceleration (Newton’s second law: \( F = ma \), so \( a = F/m \)). Stronger and better-activated cervical muscles increase the effective mass of the head-neck system and may reduce head acceleration for a given impact. Epidemiological evidence — including the work of Collins and colleagues showing that weaker neck strength was associated with higher concussion incidence in high school athletes — provides indirect support for this hypothesis. Neck-strengthening programs have been incorporated into some concussion prevention protocols, though RCT evidence for concussion risk reduction from neck strengthening programs remains limited.

Wearable Sensors and Impact Monitoring

Wearable head impact sensors embedded in helmets or skull-coupled accessories (behind-the-ear patches, mouthguard sensors) can record the magnitude and direction of head impacts in real time, providing the opportunity for real-time monitoring of cumulative impact exposure and immediate flagging of potentially concussive events. The HIT (Head Impact Telemetry) system, developed at Virginia Tech, was among the first widely used helmet-based sensor systems and has generated substantial biomechanical data on impact distributions in American football.

The validity of wearable sensors is a critical and ongoing issue. Helmet-based sensors measure the acceleration of the helmet, not of the head, introducing errors when the helmet moves relative to the skull (helmet slip). Skin-mounted behind-the-ear patches are also susceptible to skin-skull relative motion. Mouthguard sensors, which are closer to the skull, may provide better accuracy. All currently available consumer-grade wearable sensors have meaningful validity limitations that restrict the interpretation of individual impact data, though population-level and aggregate statistics from well-validated research-grade systems (like the HIT system) are useful for biomechanical research and epidemiology. No current wearable sensor has been validated for use as a clinical concussion detection device — the mechanical thresholds that trigger alerts do not reliably identify concussive events, and over-reliance on sensor data for clinical decision-making is not recommended.

Chapter 14: Special Populations

Military Personnel and Blast Injury

Concussion in military personnel — particularly in the context of the conflicts in Iraq and Afghanistan — has generated substantial research attention and has highlighted mechanisms and comorbidities not commonly encountered in sport-related concussion. Military concussion often involves blast injury as the primary mechanism: the detonation of improvised explosive devices (IEDs) generates a pressure wave (blast overpressure) that propagates through air and tissue at supersonic speed, exposing the brain to complex dynamic pressure loading distinct from the blunt impact loading of sport or vehicular collisions.

The primary blast mechanism is particularly controversial and interesting from a biomechanical perspective. Unlike blunt impact, where kinetic energy is delivered to the skull surface and transmitted as inertial loading to the brain, the primary blast pressure wave is transmitted through the body’s blood vessels — the great vessels, carotid arteries, and cerebral vasculature — generating intraluminal pressure surges that may cause direct vascular endothelial damage and perivascular tissue injury independent of skull acceleration. Animal models of blast injury have demonstrated distinct neuropathological patterns — particularly perivascular damage, oxidative stress in the corpus callosum, and neurovascular unit disruption — that may differ from blunt impact models. Whether primary blast injury produces a distinct clinical syndrome is actively debated, partly because military concussion almost invariably involves comorbidities that confound clinical characterization.

Post-traumatic stress disorder (PTSD) is the most important and clinically challenging comorbidity of military concussion. The overlapping symptom profiles of PTSD (hyperarousal, irritability, sleep disturbance, cognitive difficulty, emotional numbing, avoidance) and post-concussion symptoms (similar cognitive, sleep, and mood symptoms) make differential diagnosis extremely difficult, particularly because both conditions can result from the same traumatic event. The clinical approach requires careful temporal mapping of symptoms — did cognitive and sleep symptoms predate the traumatic event, develop immediately after the blast (suggesting direct neurological injury), or develop in the days to weeks following the event in association with intrusive re-experiencing (suggesting a PTSD trajectory)? In practice, PTSD and post-concussion syndrome frequently co-occur, requiring simultaneous multimodal management addressing both neurological and psychological dimensions of dysfunction.

Female Athletes and Hormonal Influences

Female athletes have been consistently found in epidemiological studies to experience higher rates of concussion than male athletes in comparable sport settings, to report greater acute symptom burden, and to have longer recovery durations. While some of these differences may reflect reporting bias (females may be more willing to report symptoms than males), there is substantial evidence for true biological differences in concussion epidemiology and pathophysiology by sex.

The role of sex hormones — particularly estrogen and progesterone — in modulating the neurometabolic response to brain injury has been an active area of research. Estrogen has demonstrated neuroprotective properties in animal models: it reduces neuroinflammation, supports cerebrovascular function, promotes neuronal survival, and modulates mitochondrial energy metabolism. The observation that female athletes appear to be at increased vulnerability despite estrogen’s theoretically neuroprotective properties seems paradoxical, but the resolution lies in the complex and phase-dependent nature of the menstrual cycle’s effects. Injury occurring during the luteal phase (when progesterone is high) may produce different neurometabolic responses than injury during the follicular phase, and the rapid post-injury fall in progesterone levels has been hypothesized (drawing on the progesterone TBI treatment literature) to be particularly detrimental because progesterone withdrawal may generate a neurosteroid-withdrawal syndrome analogous to benzodiazepine withdrawal.

Beyond menstrual cycle effects, female athletes also differ from male athletes in biomechanical risk factors: on average, they have lower neck strength and smaller head-neck mass, meaning that equivalent impact forces produce greater head accelerations. The structural geometry of the female skull and brain may also differ from males in ways that affect impact energy distribution. Female athletes may be at higher risk for concussion in sports where male and female athletes compete in the same collision contexts (e.g., rugby) because the contact and tackling forces are generated by players who may differ substantially in size, strength, and biomechanical training.

Athletes with ADHD

Attention deficit hyperactivity disorder (ADHD) creates a complex clinical picture in the concussion context for two reasons: first, many ADHD symptoms overlap substantially with post-concussion symptoms, making it difficult to determine which symptoms represent ADHD, which represent concussion, and which represent an interaction between the two; and second, athletes with ADHD may be at greater risk of sustaining concussion in the first place due to impulsivity, risk-taking behavior, and attentional lapses that increase exposure to dangerous situations.

In terms of post-injury assessment, athletes with ADHD present particular challenges for neuropsychological testing because their baseline performance on processing speed, attention, and working memory tests is systematically lower than population norms. Without ADHD-specific baseline testing, post-injury scores may be judged against inappropriate normative references, leading to either over-diagnosis of concussion-related cognitive impairment (when the athlete’s score is below population norms but is actually above their own ADHD-affected baseline) or under-diagnosis (if the athlete’s post-injury score, though reduced from their personal baseline, remains within the ADHD-affected range that the examiner incorrectly treats as normal). This strongly underscores the necessity of individualized baseline testing for athletes with known ADHD.

Management of stimulant medications (typically methylphenidate or amphetamine salts prescribed for ADHD) during the concussion recovery period requires clinical judgment. Some clinicians hold stimulant medications in the acute post-injury period based on theoretical concerns about their effects on the neurometabolic cascade (increased dopaminergic and noradrenergic signaling during a period of altered neurochemistry). Others argue that continuing medications maintains ADHD symptom control, which is itself important for academic and social functioning during recovery, and that there is no direct evidence of harm from continued stimulant use after concussion. There is insufficient clinical trial evidence to mandate either approach, and the decision should be individualized in consultation with the prescribing physician.

Older Athletes and Masters-Level Sport

The growing participation of older adults in masters-level competitive sport — including hockey, cycling, running, martial arts, and skiing — means that concussion in middle-aged and elderly athletes is an increasingly relevant clinical concern. The aging brain differs from the young adult brain in several ways that are relevant to concussion management: reduced neural reserve (decreased synaptic density, reduced white matter integrity, greater vulnerability to even minor perturbations), greater prevalence of cerebrovascular disease (which can complicate both the acute presentation and recovery), and higher baseline use of anticoagulant and antiplatelet medications (which significantly elevate the risk of intracranial hemorrhage and lower the threshold for CT imaging).

Recovery from concussion appears to take longer in older adults than in young adults, consistent with reduced neural reserve and greater pre-existing neurological vulnerability. The threshold for neuroimaging is lower in older patients, particularly those on anticoagulation or with recent falls, and neurological follow-up may need to be more protracted. Cognitive rehabilitation may need to address age-related cognitive changes as context for interpreting post-injury performance. Return-to-sport decisions must balance the evidence for benefits of continued physical activity in aging — which include strong neuroprotective effects — against the risk of recurrent concussion and cumulative neurological injury.

Chapter 15: Integration — From Assessment to Long-Term Management

Multimodal Assessment as Standard of Care

The contemporary standard of care for concussion assessment recognizes that no single test captures the full complexity of this condition. The Amsterdam consensus statement (2023) explicitly endorses a multimodal assessment approach that integrates symptom self-report, cognitive testing, balance and vestibular assessment, oculomotor assessment, and where indicated, advanced neuroimaging and biomarker analysis. The rationale is straightforward: different assessment tools examine different aspects of neural function that may be differentially affected in different patients, and reliance on any single tool — whether symptom inventory, cognitive testing, or BESS — will miss significant dysfunction in a subset of patients.

In practical terms, this means that a concussed athlete who reports being “symptom-free” at 2 weeks does not automatically receive return-to-sport clearance. Objective assessment findings — abnormal VOMS, below-baseline ImPACT scores, BESS errors, abnormal tandem gait times, or abnormal NPC — may indicate continued dysfunction even in the absence of subjective symptoms. This discrepancy between subjective and objective recovery occurs for several reasons: some athletes deny or underreport symptoms because of motivation to return to sport; some genuinely feel better despite objective signs of residual dysfunction; and some have habituated to chronic symptoms that no longer feel abnormal to them even though they represent deviation from pre-injury function. Objective assessment provides a safeguard against these limitations of symptom self-report.

The return-to-sport decision should ideally require: resolution of all symptoms; return to baseline on neuropsychological testing; return to baseline on balance and vestibular assessment; normal oculomotor function including NPC; normal Buffalo Treadmill Test (or equivalent sub-threshold exercise tolerance); and medical clearance from a physician with expertise in concussion management. In practice, not all of these elements will be available in every clinical setting, but the principle of multimodal, objective assessment guiding return-to-sport decisions represents the evidence-informed standard.

Shared Decision-Making and Patient Education

Concussion management is fundamentally a collaborative enterprise requiring active engagement and informed decision-making by the patient (and, for minor patients, by their parents or guardians). Shared decision-making — in which the clinician presents the evidence, options, risks, and uncertainties transparently and the patient’s values and preferences are explicitly incorporated into the management plan — is particularly important in concussion because of the inherent uncertainties in recovery timeline prediction, the long-term risk landscape (including questions about CTE that cannot currently be answered definitively for individual patients), and the substantial impact of management decisions on athletes’ lives, identities, and social relationships.

Patient education should address: what concussion is (a functional rather than structural brain injury), what the expected recovery course is (and that it varies substantially between individuals), what symptoms to monitor for, when to seek urgent medical attention (red flag symptoms: worsening headache, repeated vomiting, seizures, focal neurological signs, progressive confusion — which may indicate more serious structural injury), the rationale for graduated return-to-sport protocols, and the evidence on long-term risks including the CTE debate with appropriately calibrated uncertainty. Framing the recovery process as active rather than passive — emphasizing what the patient can do (light activity below symptom threshold, graduated aerobic exercise, sleep hygiene, vestibular exercises) rather than simply what they cannot do — reduces learned helplessness and kinesiophobia and promotes a more adaptive recovery orientation.

The Future: Biomarkers, Precision Medicine, and Technology

The next decade of concussion research holds considerable promise for advancing from the current symptom- and behavior-based paradigm toward one that incorporates objective biological measurement of injury severity, vulnerability, and recovery. Blood biomarkers — particularly GFAP and NfL measured acutely — are already showing clinical utility in stratifying patients by injury severity and in predicting prolonged recovery, with large multicenter validation studies underway. The eventual clinical application of blood biomarkers for concussion triage could allow emergency departments to rule out structural injury more efficiently (reducing unnecessary CT scans) and to identify patients at high risk for prolonged recovery who need early referral to specialized concussion care.

Precision medicine approaches — tailoring treatment based on an individual patient’s biological profile, symptom subtype, and modifiable risk factors — represent the aspirational endpoint of post-concussion management. Rather than applying the same graduated rest-and-return protocol to every concussed patient, a precision approach would: identify the dominant pathophysiological subtype driving symptoms (vestibular, oculomotor, cervicogenic, mood/anxiety, sleep, cognitive/fatigue, or combinations); match treatment intensity and focus to that subtype from the earliest assessment; use biomarkers to track biological recovery independently of subjective symptoms; and incorporate genetic, hormonal, and prior exposure data to refine prognosis and risk communication. This vision is not yet clinical reality, but the research infrastructure — prospective cohort studies, multimodal outcome batteries, biobank collections — being built across North America and internationally is progressively closing the gap between aspiration and practice.

Wearable and digital health technologies will increasingly play a role in concussion prevention and management. Smartphone-based cognitive assessment tools that can be self-administered before and after suspected injuries are already commercially available. Ecological momentary assessment — real-time symptom tracking via smartphone app — may improve the granularity and accuracy of symptom data, replacing the approximation inherent in end-of-day global recall assessments. Artificial intelligence applications that integrate multimodal data from sensors, imaging, biomarkers, and clinical assessment to generate individualized risk predictions and treatment recommendations are an area of active development. These technologies, if appropriately validated and deployed with appropriate clinical oversight, have the potential to substantially improve both the equity (by extending access to high-quality assessment beyond specialist centers) and the quality (through more precise, data-informed decision-making) of concussion care across populations.

Chapter 16: Synthesis — Key Principles Across the Course

Core Principles of Concussion Science and Practice

The body of knowledge assembled across these chapters converges on a set of core principles that should guide both clinical practice and scientific interpretation in the concussion field.

The first principle is that concussion is a functional rather than structural disruption. The normal appearance of standard neuroimaging does not indicate absence of injury; it indicates the limit of what standard structural imaging can detect. The true injury is at the level of cellular and molecular physiology — disrupted ionic gradients, impaired axonal transport, mitochondrial energy failure, and transient circuit dysfunction — that is invisible to CT and standard MRI but is measurable with advanced techniques (DTI, fMRI, MRS, PET) and increasingly with blood biomarkers. This principle has practical implications: it means that athletes cannot be returned to sport on the basis of a normal CT scan, and it means that the absence of objective structural findings should not lead clinicians to dismiss or minimize patients’ symptom reports.

The second principle is that individual variability in concussion presentation and recovery is the rule, not the exception. Population-level statistics (the majority recover in 1–2 weeks, most athletes have normal neuroimaging) describe the center of the distribution but tell us little about any specific individual. Factors including age, sex, hormonal status, prior concussion history, pre-existing psychological conditions, genetic background (including APOE genotype), and sport-specific biomechanical exposure profiles all influence where any particular patient falls on the recovery curve. Clinical management must be individualized accordingly, resisting the temptation to apply uniform protocols to heterogeneous patients.

The third principle is that the management of concussion has moved decisively away from passive rest toward proactive, subthreshold-guided rehabilitation. The evidence that early sub-threshold aerobic exercise shortens recovery, that vestibular rehabilitation accelerates resolution of vestibular dysfunction, that vision therapy resolves convergence insufficiency, and that CBT addresses anxiety and mood components of PPCS collectively means that the clinician’s role is not to prescribe rest and wait, but to identify the dominant pathophysiological subtypes driving symptoms and to match targeted rehabilitative interventions to those subtypes from the earliest possible clinical encounter.

The fourth principle is that concussion exists within a broader life context — sport, school, family, identity, mental health — that is inseparable from the clinical management challenge. Athletes are not simply brains attached to bodies; they are people for whom sport participation is often a central source of identity, social connection, and psychological well-being. The disruption of this identity and connection during concussion recovery is itself a source of psychological harm that can perpetuate the recovery process. Clinicians who attend only to the neurological dimensions of concussion while ignoring the psychological, social, and contextual dimensions provide incomplete care.

The fifth principle is one of epistemic humility about long-term risk, particularly regarding CTE. The current evidence base establishes a strong association between repetitive traumatic brain injury and CTE neuropathology but cannot yet reliably determine for any individual former athlete what their personal risk of CTE is, whether they currently have CTE pathology, or what preventive interventions would modify that risk. This uncertainty does not justify dismissing the concern — the association is strong enough and the potential consequences serious enough to demand preventive action at the policy and equipment level. But it does require that clinical communication about CTE be calibrated to the actual state of evidence rather than to the most alarming or most reassuring extreme of the range of interpretation.

Looking Forward: Evidence Gaps and Research Priorities

Despite remarkable scientific progress in the concussion field over the past two decades, important evidence gaps remain that constrain clinical management and public policy. The most pressing include: validated blood biomarkers that can confirm concussion diagnosis at the point of care and track recovery objectively; prospective longitudinal studies of former contact sport athletes with in vivo CTE biomarkers to establish the true prevalence and risk factors for CTE in living individuals; RCTs of specific rehabilitative interventions (vestibular therapy, vision therapy, aerobic exercise protocols) with sufficient sample sizes and standardized outcome measures to generate practice-changing evidence; understanding of optimal management strategies for special populations (pediatric, female athletes, military, elderly); and development of effective preventive interventions — both engineering (better helmets) and behavioral (rule changes, technique modification) — with documented effectiveness in reducing concussion incidence in real-world sport settings.

These gaps represent not just academic questions but urgent clinical and public health priorities. Millions of concussions occur annually, a significant proportion producing prolonged disability and potentially contributing to long-term neurological risk. The field has made extraordinary strides in establishing the neurobiological framework, developing clinical assessment tools, and building the epidemiological foundation for evidence-based management. The coming decade of research — leveraging biobanks, advanced neuroimaging, wearable sensors, multisite clinical networks, and precision medicine frameworks — will determine how much further this foundation can be built upon to deliver meaningfully better outcomes for the individuals who sustain these injuries.

These notes are compiled for academic study purposes. Primary sources should be consulted for clinical decision-making. Key references include the Berlin (McCrory et al., 2017) and Amsterdam (Patricios et al., 2023) Consensus Statements on Concussion in Sport published in the British Journal of Sports Medicine; Giza and Hovda’s neurometabolic cascade reviews in Neurosurgery; McKee et al.’s CTE staging publications in Brain; Leddy et al.’s Buffalo treadmill protocol work; and the vestibular and oculomotor rehabilitation literature in the Journal of Head Trauma Rehabilitation and Lancet Neurology.